- Assessing Differences in Mortality Rates and Risk Factors Between Hispanic and Non-Hispanic Patients With Cystic Fibrosis in California. Buu MC, Sanders LM, Mayo JA, Milla CE, Wise PH. Chest. 2016 Feb;149(2):380-389. doi: 10.1378/chest.14-2189.
- Loss of PPARγ in endothelial cells leads to impaired angiogenesis. Vattulainen-Collanus S, Akinrinade O, Li M, Koskenvuo M, Li CG, Rao SP, de Jesus Perez V, Yuan K, Sawada H, Koskenvuo JW, Alvira CM, Rabinovitch M, Alastalo TP. J Cell Sci. 2016 Feb 15;129(4):693-705. doi: 10.1242/jcs.169011.
- The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosis. Mirković B, Lavelle GM, Azim AA, Helma K, Gargoum FS, Molloy K, Gernez Y, Dunne K, Renwick J, Murphy P, Moss RB, Greene CM, Gunaratnam C, Chotirmall SH, McElvaney NG. J Allergy Clin Immunol. 2016 Feb;137(2):436-443.e9. doi: 10.1016/j.jaci.2015.07.045.
- Treating allergic bronchopulmonary aspergillosis: the way forward. Moss RB. Eur Respir J. 2016 Feb;47(2):385-7. doi: 10.1183/13993003.01816-2015.